- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04291651
UCSF PANC Cyste Registry (UCSF PCR)
Populationsbaseret analyse af neoplastiske ændringer i cystiske læsioner i bugspytkirtlen.
Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study develops a large, prospectively managed, electronic, patient-directed pancreatic cyst registry based at UCSF. The UCSF Pancreatic Cystic Lesions Registry (PANC Cyst) will facilitate work to improve clinical care and understanding of pancreatic cysts by prospective follow-up of patients with cystic lesions, especially the diagnostically challenging small cysts, to identify factors related to cyst formation and progression to malignancy. Longitudinal data capture that includes clinical outcomes will also enable us to more precisely define anatomic, radiographic and biomarker information that can be used to differentiate populations of patients for whom surgery is indicated, surveillance is warranted, or no further evaluation is necessary.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Charysa Santos, BS
- Telefonnummer: 415-514-6914
- E-mail: Charysa.Santos@ucsf.edu
Undersøgelse Kontakt Backup
- Navn: Kimberly S Kirkwood, MD
- Telefonnummer: 415-502-5577
- E-mail: kim.kirkwood@ucsf.edu
Studiesteder
-
-
California
-
San Francisco, California, Forenede Stater, 94143
- Rekruttering
- University of California, San Francisco
-
Kontakt:
- Charysa Santos, BS
- Telefonnummer: 415-514-6914
- E-mail: Charysa.Santos@ucsf.edu
-
Kontakt:
- M.D.
- Telefonnummer: 877-827-3222
- E-mail: cancertrials@ucsf.edu
-
Ledende efterforsker:
- Kimberly Kirkwood, MD
-
Ledende efterforsker:
- Paige M Bracci, PhD, MPH, MS
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
The majority of patients in this study will be over the age of 60 years old, due to the natural age distribution of pancreatic cysts. There will be an approximately even distribution of males and females.
Beskrivelse
Inclusion Criteria:
- The inclusion criteria for this study are intentionally broad. Eligible patients for prospective enrollment will include
- Adults ≥ 30 years of age
- Have a radiographic or endoscopic diagnosis of at least one pancreatic cysts regardless of treatment status,
- No history of pancreatic cancer,
- Can speak and read English,
- Have access to a computer or mobile device (~95% of U.S. population); and
- Are able to complete an electronic informed consent.
Exclusion Criteria:
- Patients who don't speak English,
- Don't have access to a computer or mobile device; or
- Patients who have a cancer diagnosis.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Retrospective
The registry will be populated with a retrospective cohort of patients previously identified as having pancreatic cysts. |
|
|
Prospective
The prospectively enrolled patients in this study are the primary population of interest. |
There are no study-specific interventions, as this is a prospective registry. However, patients will be asked to complete approximately 1-2 hours worth of surveys on things such as demographics, medical and surgical history, and pancreatic cyst-specific questionnaires. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Cancer
Tidsramme: 1-10 years
|
While not the primary outcome measure, the development of cancer from a pancreatic cyst is a critically important study endpoint, which the investigators do not expect to be frequent occurrence. |
1-10 years
|
|
Indolency
Tidsramme: 1-10 years
|
If a patient with a pancreatic cyst experiences no or minimal change in size, and no development of worrisome or high-risk stigmata (Tanaka 2017), this will be considered to be an indolent lesion. Most patients will fall under this category. |
1-10 years
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Kimberly S Kirkwood, MD, University of California, San Francisco
- Ledende efterforsker: Paige M Bracci, PhD, MPH, MS, University of California, San Francisco
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Sygdomme i det endokrine system
- Neoplasmer efter sted
- Neoplasmer
- Neoplasmer efter histologisk type
- Neoplasmer i fordøjelsessystemet
- Sygdomme i fordøjelsessystemet
- Neoplasmer i endokrine kirtler
- Neoplasmer, kirtel og epitel
- Adenom
- Cyster
- Neoplasmer, cystiske, mucinøse og serøse
- Neoplasmer, duktale, lobulære og medullære
- Cystadenom
- Pancreas intraduktale neoplasmer
- Bugspytkirtel neoplasmer
- Bugspytkirtelcyste
- Pancreassygdomme
- Mucocele
- Cystadenom, serøs
- Sundhedsvæsenets kvalitet, adgang og evaluering
- Undersøgelsesteknikker
- Epidemiologiske metoder
- Dataindsamling
- Evalueringsmekanismer til sundhedsvæsenet
- Sundhedskvalitet
- Folkesundhed
- Miljø og folkesundhed
- Undersøgelser og spørgeskemaer
Andre undersøgelses-id-numre
- 214521
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .